A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.
Pfizer
Pfizer
Ocellaris Pharma, Inc.
Yale University
Bolt Biotherapeutics, Inc.
HiFiBiO Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
Pfizer
Pfizer
NuCana plc
NRG Oncology
Turnstone Biologics, Corp.
Incyte Corporation
Incyte Corporation
University of California, San Diego
Sotio Biotech Inc.
ImaginAb, Inc.
Molecular Templates, Inc.
Inhibrx Biosciences, Inc
Novartis
Pfizer
ADC Therapeutics S.A.
Pfizer
Vanderbilt University Medical Center
University of Florida
Novartis
Fate Therapeutics
Fate Therapeutics
4D pharma plc
Nektar Therapeutics
Duke University
Genocea Biosciences, Inc.
TC Biopharm
MacroGenics
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Yale University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Alliance for Clinical Trials in Oncology
Mayo Clinic
St. Louis University
Celldex Therapeutics
National Institutes of Health Clinical Center (CC)
Mirna Therapeutics, Inc.
Seoul National University Hospital
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Calando Pharmaceuticals
National Cancer Institute (NCI)
Cytheris SA